Skip to content
Open access · CC-BY via OpenAlex

Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics

Marie Dagonnier, Ira Cooke, Pierre Faou, Kate Sidon, Helen Margaret Dewey, Geoffrey Alan Donnan, David William Howells

Biomarker Insights · 2017 · ▲ 12 citations

Abstract

Application of acute therapies such as thrombolysis for ischaemic stroke (IS) is constrained because of diagnostic uncertainty and the dynamic nature of stroke biology. To investigate changes in blood proteins after stroke and as a result of thrombolysis treatment we performed label-free quantitative proteomics on serum samples using high-resolution mass spectrometry and long high-performance liquid chromatography gradient (5 hours) combined with a 50-cm column to optimise the peptide separation. We identified (false discovery rate [FDR]: 1%) and quantified a total of 574 protein groups from a total of 92 samples from 30 patients. Ten patients were treated by thrombolysis as part of a randomised placebo-controlled trial and up to 5 samples were collected from each individual at different time points after stroke. We identified 26 proteins differently expressed by treatment group (FDR: 5%) and significant changes of expression over time for 23 proteins (FDR: 10%). Molecules such as fibrinogen and C-reactive protein showed expression profiles with a high-potential clinical utility in the acute stroke setting. Protein expression profiles vary acutely in the blood after stroke and have the potential to allow the construction of a stroke clock and to have an impact on IS treatment decision making.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1177/1177271917749216
Canonical
link ↗
Fetched
2026-10-14 MST

Cite this

APA
Dagonnier, M., Cooke, I., Faou, P., Sidon, K., Dewey, H.M., Donnan, G.A., &amp; Howells, D.W. (2017). Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics. <em>Biomarker Insights</em>. https://doi.org/10.1177/1177271917749216
Vancouver
Dagonnier M, Cooke I, Faou P, Sidon K, Dewey HM, Donnan GA, et al. Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics. Biomarker Insights. 2017. doi:10.1177/1177271917749216.
BibTeX
@article{marie2017Discov, title = {Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics}, author = {Marie Dagonnier and Ira Cooke and Pierre Faou and Kate Sidon and Helen Margaret Dewey and Geoffrey Alan Donnan and David William Howells}, journal = {Biomarker Insights}, year = {2017}, doi = {10.1177/1177271917749216}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings